publication venue for
- MCL1 and DEDD Promote Urothelial Carcinoma Progression. 17:1294-1304. 2019
- Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate. 17:446-456. 2019
- Genomic cfDNA Analysis of Aqueous Humor in Retinoblastoma Predicts Eye Salvage: The Surrogate Tumor Biopsy for Retinoblastoma. 16:1701-1712. 2018
- Targeted AKT inhibition in prostate cancer cells and spheroids reduces aerobic glycolysis and generation of hyperpolarized [1-13C] lactate. 16:453-460. 2018
- Chromosome 20q amplification defines a subtype of microsatellite stable, left-sided colon cancers with wild-type RAS/RAF and better overall survival. 15:708-713. 2017
- Metabolic profiling in formalin-fixed and paraffin-embedded prostate cancer tissues. 15:439-447. 2017
- Pathology-driven comprehensive proteomic profiling of the prostate cancer tumor microenvironment. 15:281-293. 2017
- Induction of PSMA and internalization of an anti-PSMA mAb in the vascular compartment. 14:1045-1053. 2016
- Cancer-associated fibroblasts induce a collagen cross-link switch in tumor stroma. 14:287-95. 2016
- Identification of targetable kinase alterations in patients with colorectal carcinoma that are preferentially associated with wild-type RAS/RAF. 14:296-301. 2016
- Defining ATM-independent functions of the mre11 complex with a novel mouse model. 14:185-95. 2016
- Measuring PI3K activation: Clinicopathologic, immunohistochemical, and RNA expression analysis in prostate cancer. 13:1431-40. 2015
- AKT1 E17K in colorectal carcinoma is associated with BRAF V600E but not MSI-H status: A clinicopathologic comparison to PIK3CA helical and kinase domain mutants. 13:1003-8. 2015
- Genome-wide profiling of track kidneys shows similarity to the human ccRCC transcriptome. 13:870-8. 2015
- The chemokine (CCL2-CCR2) signaling axis mediates perineural invasion. 13:380-90. 2015
- The role of nitric oxide synthase uncoupling in tumor progression. 13:1034-43. 2015
- p53 promotes cell survival due to the reversibility of its cell-cycle checkpoints. 13:16-28. 2015
- Prostate cancer genetic-susceptibility locus on chromosome 20q13 is amplified and coupled to androgen receptor-regulation in metastatic tumors. 12:184-9. 2014
- Autophagy-dependent metabolic reprogramming sensitizes tsc2-deficient cells to the antimetabolite 6-aminonicotinamide. 12:48-57. 2014
- Phosphoproteomic profiling reveals IL6-mediated paracrine signaling within the Ewing sarcoma family of tumors. 12:1740-54. 2014
- The Twist box domain is required for Twist1-induced prostate cancer metastasis. 11:1387-400. 2013
- Metabolic alterations in lung cancer-associated fibroblasts correlated with increased glycolytic metabolism of the tumor. 11:579-92. 2013
- Alpha-CaMKII plays a critical role in determining the aggressive behavior of human osteosarcoma. 11:349-59. 2013
- Inhibition of TWIST1 leads to activation of oncogene-induced senescence in oncogene-driven non-small cell lung cancer. 11:329-38. 2013
- KRASG12D- and BRAFV600E-induced transformation of murine pancreatic epithelial cells requires MEK/ERK-stimulated IGF1R signaling. 10:1228-39. 2012
- The proteasome activator PA200 regulates tumor cell responsiveness to glutamine and resistance to ionizing radiation. 10:937-44. 2012
- Notch signaling contributes to lung cancer clonogenic capacity in vitro but may be circumvented in tumorigenesis in vivo. 9:1746-54. 2011
- Imatinib upregulates compensatory integrin signaling in a mouse model of gastrointestinal stromal tumor and is more effective when combined with dasatinib. 8:1271-83. 2010
- Regional control of tumor growth. 8:1198-206. 2010
- Upregulation of MMP-2 by HMGA1 promotes transformation in undifferentiated, large-cell lung cancer. 7:1803-12. 2009
- Rembrandt: Helping personalized medicine become a reality through integrative translational research. 7:157-67. 2009
- Induction of antiproliferative connective tissue growth factor expression in Wilms' tumor cells by sphingosine-1-phosphate receptor 2. 6:1649-56. 2008
- MDM2 gene amplification is correlated to tumor progression but not to the presence of SNP309 or TP53 mutational status in primary colorectal cancers. 6:205-11. 2008
- Acquisition of stable inducible up-regulation of nuclear factor-κB by tumor necrosis factor exposure confers increased radiation resistance without increased transformation in breast cancer cells. 6:78-88. 2008
- Genomic changes and gene expression profiles reveal that established glioma cell lines are poorly representative of primary human gliomas. 6:21-30. 2008
- Sustained VEGF blockade results in microenvironmental sequestration of VEGF by tumors and persistent VEGF receptor-2activation. 6:1-9. 2008
- Lysophosphatidic acid down-regulates stress fibers and up-regulates pro-matrix metalloproteinase-2 activation in ovarian cancer cells. 5:121-31. 2007
- Inhibition of matrilysin expression by antisense or RNA interference decreases lysophosphatidic acid-induced epithelial ovarian cancer invasion. 4:831-41. 2006
- Epithelial-restricted gene profile of primary cultures from human prostate tumors: A molecular approach to predict clinical behavior of prostate cancer. 4:79-92. 2006
- Mammalian target of rapamycin promotes vincristine resistance through multiple mechanisms independent of maintained glycolytic rate. 3:635-44. 2005
- Frequent HIN-1 promoter methylation and lack of expression in multiple human tumor types. 2:489-94. 2004
- Fatty acid synthase expression defines distinct molecular signatures in prostate cancer. 1:707-15. 2003
- Heregulin targets γ-catenin to the nucleolus by a mechanism dependent on the DF3/MUC1 oncoprotein. 1:765-75. 2003
- Identification and characterization of retinoic acid receptor β2 target genes in F9 teratocarcinoma cells. 1:619-30. 2003
- Direct evidence that Bcr-Abl tyrosine kinase activity disrupts normal synergistic interactions between kit ligand and cytokines in primary primitive progenitor cells. 1:176-85. 2003
- Increased expression of epidermal growth factor receptor induces sequestration of extracellular signal-related kinases and selective attenuation of specific epidermal growth factor-mediated signal transduction pathways. 1:219-33. 2003
- Harnessing and optimizing the interplay between immunotherapy and radiotherapy to improve survival outcomes 2018
- Dissecting the dual role of AMPK in cancer: From experimental to human studies 2015
- The N-myc oncogene: Maximizing its targets, regulation, and therapeutic potential 2014
- The role of inflammatory pathways in cancer-associated cachexia and radiation resistance 2013